Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles J Parker

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Hematology. American Society of Hematology. Education Program|December 14, 2011
Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapyCharles J Parker
Current Protocols in Immunology|April 25, 2008
Isolation and functional assay of the membrane complement inhibitors CD55 (DAF) and CD59 (MIRL)Charles J Parker
Experimental Hematology|March 24, 2007
The pathophysiology of paroxysmal nocturnal hemoglobinuriaCharles J Parker
Hematology. American Society of Hematology. Education Program|December 17, 2008
Paroxysmal nocturnal hemoglobinuria: an historical overviewCharles J Parker
Current Opinion in Hematology|March 8, 2012
Paroxysmal nocturnal hemoglobinuriaCharles J Parker
Hematology/Oncology Clinics of North America|March 31, 2009
Bone marrow failure syndromes: paroxysmal nocturnal hemoglobinuriaCharles J Parker
British Journal of Haematology|March 29, 2002
Historical aspects of paroxysmal nocturnal haemoglobinuria: 'defining the disease'Charles J Parker
Hematology. American Society of Hematology. Education Program|December 4, 2016
Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuriaCharles J Parker
International Journal of Hematology|March 12, 2003
Management issues in paroxysmal nocturnal hemoglobinuriaGabrielle Meyers, Charles J Parker
Frontiers in Bioscience (Scholar Edition)|June 3, 2010
CD4 (+)CD25 (+)Foxp3 (+) regulatory T cells and hematologic malignanciesTodd W Kelley, Charles J Parker
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Hematology. American Society of Hematology. Education Program|December 14, 2011
Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapyCharles J Parker
Current Protocols in Immunology|April 25, 2008
Isolation and functional assay of the membrane complement inhibitors CD55 (DAF) and CD59 (MIRL)Charles J Parker
Experimental Hematology|March 24, 2007
The pathophysiology of paroxysmal nocturnal hemoglobinuriaCharles J Parker
Hematology. American Society of Hematology. Education Program|December 17, 2008
Paroxysmal nocturnal hemoglobinuria: an historical overviewCharles J Parker
Current Opinion in Hematology|March 8, 2012
Paroxysmal nocturnal hemoglobinuriaCharles J Parker
Hematology/Oncology Clinics of North America|March 31, 2009
Bone marrow failure syndromes: paroxysmal nocturnal hemoglobinuriaCharles J Parker
British Journal of Haematology|March 29, 2002
Historical aspects of paroxysmal nocturnal haemoglobinuria: 'defining the disease'Charles J Parker
Hematology. American Society of Hematology. Education Program|December 4, 2016
Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuriaCharles J Parker
International Journal of Hematology|March 12, 2003
Management issues in paroxysmal nocturnal hemoglobinuriaGabrielle Meyers, Charles J Parker
Frontiers in Bioscience (Scholar Edition)|June 3, 2010
CD4 (+)CD25 (+)Foxp3 (+) regulatory T cells and hematologic malignanciesTodd W Kelley, Charles J Parker
Pageof 4